Hodgkin's Lymphoma

Hodgkin's lymphoma, previously known as Hodgkin's disease, is a type of lymphoma, which is a type of cancer originating from white blood cells called lymphocytes. It was named after Thomas Hodgkin, who first described abnormalities in the lymph system in 1832.
What is Hodgkin's Lymphoma?

Hodgkin’s lymphoma or Hodgkin’s disease is a form of cancer that affects the lymphatic system. The cancer originates in the lymphocytes, which are white blood cells. The disease was so named after Thomas Hodgkin, who first described the condition in 1832.

Read More

Overview

Feature Articles

Latest Hodgkin's Lymphoma News and Research

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

International collaboration secures €1M grant to investigate new treatment target for lymphoma

International collaboration secures €1M grant to investigate new treatment target for lymphoma

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Biomarker shows potential to predict immunotherapy benefit for breast cancer patients

Biomarker shows potential to predict immunotherapy benefit for breast cancer patients

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

MDC researchers develop a potent weapon against lymphomas

MDC researchers develop a potent weapon against lymphomas

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Study explores link between personal use of hair dyes and cancer risk

Study explores link between personal use of hair dyes and cancer risk

FDA provides update on adverse events associated with breast implants

FDA provides update on adverse events associated with breast implants

New cancer vaccine shows promising signs in preclinical studies

New cancer vaccine shows promising signs in preclinical studies

Innovent Biologics and MD Anderson to develop sintilimab injection for rare cancers

Innovent Biologics and MD Anderson to develop sintilimab injection for rare cancers

People with a cancer history have increased risk of developing atrial fibrillation

People with a cancer history have increased risk of developing atrial fibrillation

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

UAB seminar on the extraordinary science of the immune system

UAB seminar on the extraordinary science of the immune system